Cardinal Health (CAH) recently traded around US$205 per share, marking a 48.7% gain over the last year and a massive 162.3% return over the past three years after a total five-year run of 272%. Simply Wall St analyzes whether this strong price appreciation has fully...
William Blair has initiated coverage on Cardinal Health (NYSE: CAH) with an Outperform rating, positioning the pharma distributor as a "stealth compounder" driven by a durable competitive moat. The firm highlights that Cardinal's distribution platform and scale allow it to capture value from demographic tailwinds...
The article analyzes Cardinal Health (NYSE:CAH) as an investment candidate characterized by its strong profitability and recent earnings growth, contrasting it with higher-risk "story stocks" that lack revenue. Over the past year, Cardinal Health's earnings per share (EPS) increased significantly from US$5.41 to US$7.06, representing...
Cardinal Health (CAH) shares closed the session at $215.13, rising 1.11% despite underperforming the broader market, which saw the S&P 500 gain 2.51%, the Dow rise 2.85%, and the Nasdaq climb 2.8%. Over the past month, CAH stock has declined by 1.97%, a better performance...
Cardinal Health Inc. (CAH) shares climbed 1.11% to reach $215.13 on Wednesday, marking the stock's second consecutive day of gains. The performance occurred amid a broadly positive trading session in the broader market, with the S&P 500 Index rising 2.51% to close at 6,782.81 and...
